title: Uveal Melanoma Patient-Derived Xenografts.
abstract: The prognosis of uveal melanoma (UM) remains poor due to a high risk of metastatic disease. No effective therapies have been described for metastatic UM, and new therapies are needed to improve the outcome for these patients. To achieve this goal, new preclinical animal models are needed. Existing animal models, including genetically engineered mice and orthotopic xenograft models in immunodeficient animals, are inadequate for modelling human disease. In this review, we present the development and characterization of a large panel of UM patient-derived xenografts (PDXs). Based on molecular features as identified in patient tumors, i.e. histopathological classification, specific gene mutations, as well as genomic and gene expression profiles, we show that PDXs closely resemble many important genetic and histological aspects of human UM with a remarkable stability over the course of their in vivo maintenance. Our techniques for establishing and maintaining primary UMs as xenograft tumors in immunodeficient mice provide a high degree of genetic conservation between the primary tumor and its xenograft over multiple in vivo passages. These models therefore represent a significant advance in the resources available for drug screening and studies of the pathogenesis of UM.
authors.affiliation: Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Carita
authors.affiliation: Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France.
authors.forename: Fariba
authors.initials: F
authors.lastname: Némati
authors.affiliation: Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris, France.
authors.forename: Didier
authors.initials: D
authors.lastname: Decaudin
keywords: Gene mutations; Genomic and gene expression profiles; In vivo experiments; Patient-derived xenograft; Uveal melanoma